Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JANA Partners is a prominent event-driven activist hedge fund founded in 2001 by Barry Rosenstein. The firm specializes in identifying undervalued companies and utilizing active engagement to drive strategic, operational, and governance changes. JANA is particularly active in the healthcare and life sciences sectors, having influenced major entities like LabCorp, Bristol Myers Squibb, and Encompass Health. Through its JANA Strategic Investment Fund, the firm often secures board representation to advocate for corporate spin-offs, sales, or improved capital allocation. Their approach combines deep fundamental research with a track record of successful shareholder activism to unlock value within the healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JANA Partners.